Carter's: The Tariff Refund Is Doing All The Lifting

kev_larFounder & Lead Developer
·CRI forecast →

⚠️ Not financial advice. This post is for informational and educational purposes only. Forecasts and commentary are model outputs and opinions, may be inaccurate, and are not a recommendation to buy or sell any security or asset. Do your own research. AI-assisted: this article was drafted with AI and reviewed by a human before publishing.

Let's be straight about Carter's (CRI) earnings, because the tape is telling a story the headlines are not.

The company reported Q2 FY2026 back on July 31, and on paper it was a beauty: consolidated sales up 5% to roughly $615M, five straight quarters of positive U.S. comparable sales, and an EPS of $0.26 against a whisper of $0.02. Adjusted operating profit jumped 54%. The stock ran, then gave it all back — down roughly 14% since that report, and down about 16% over the last quarter. It's now sitting near $32.50, up about 3% on the week.

So what happened? Why did a beat-and-rise-and-run stock lose a sixth of its value?

Because the market read the fine print.

Here's the thing nobody leads with: a big chunk of that profitability was a one-time gift. Carter's booked roughly $128M in cost of goods sold as a one-time IEEPA tariff refund, plus about $4M in interest income — call it $132M total. That single line item blew GAAP operating margin out to 22.7% from 0.7% a year earlier. Strip the refund out and the underlying margin profile is, by the desk's own read, still compressed. You don't build a thesis on a windfall you'll never see twice.

And there's a real problem waiting at the end of October.

(Some older calendars floated a Nov. 2 date, but that one's gone stale and I wouldn't stake a plan on it.) Consensus, for what it's worth, wants an EPS of around $0.85 to $0.89 on revenue near $750M. The options market has priced in roughly a ±12% move — a $4 swing. Given the size of the last surprise and the fact that the year-ago base was propped up by that same tariff refund, I'd treat both the number and the expected reaction with a healthy skepticism.

Now, the bear case isn't a strawman — it's the whole reason the stock got beaten down.

This is a tariff-driven business. New Section 301 tariffs now hit imports from roughly 60 countries, and average unit costs rose a low-teens percentage in the first half of the year. Carter's just issued $575M in senior notes maturing in 2031 at a 7.375% coupon, which meaningfully raises its interest burden. A new CEO, Sharon Price John, took over in June with a promise of a second-half margin inflection — which sounds great until you realize "new CEO" and "margin turn" are two things you have to actually watch happen, not just hear announced. There's even an unquantified IP-infringement matter tucked in the footnotes.

Which brings us to the value argument, because that's the only reason this stock hasn't been left for dead.

On the cheap end: the desk data shows a P/E around 6x, a forward P/E near 9.4x, and a price-to-sales of 0.40. That's a fraction of the ~16.8x industry multiple. Cash ballooned to $654M from $487M at year-start. The dividend pays a 3% yield. And there's a $38 price target out there against the ~$32 stock.

Here's where I have to earn my keep. That 6x multiple looks absurdly cheap — until you remember it's sitting on top of a $132M one-time refund that inflated the denominator. If you're pricing Carter's on reported earnings, you're buying a discount on a number that isn't repeatable. The forward multiple is closer to reality, and it's still cheap. But cheap is not the same as cheap-and-right.

My take? Carter's is a tariff and execution story wearing a value-stock costume. The comps are genuinely encouraging — five quarters of positive U.S. comparable sales is not nothing in discretionary apparel. The balance sheet is fine. But you've got rising import costs, a pricier capital structure, a new CEO who has to deliver on a promised turn, and a reported earnings figure that would look a lot uglier without the tariff windfall.

The Oct. 26 print is the catalyst that resolves all of this at once. If management shows the margin inflection is real and the tariff base is clearing — not just being refunded — the stock has enormous room to re-rate toward that $38 target. If the underlying margins stay compressed and they lean on another one-time item to make the number, the "cheap" becomes a value trap fast, especially with a 21% short float adding fuel to any disappointment.

Don't fall in love with the 6x. Fall in love with what happens after October 26. The tariff refund got you to the door; the real business has to knock.

More on CRI


Market commentary from the K3vl4r desk — not personalized investment advice. More posts →